Literature DB >> 3031004

Prejunctional beta 1-adrenoceptors inhibit cholinergic transmission in canine bronchi.

A H Danser, R van den Ende, R R Lorenz, N A Flavahan, P M Vanhoutte.   

Abstract

The aim of the present study was to determine in canine bronchi the effects produced by norepinephrine (released from adrenergic nerve terminals) on cholinergic neurotransmission. Electrical stimulation of canine bronchi activates cholinergic and adrenergic nerve fibers. The adrenergic neuronal blocker, bretylium tosylate, inhibited the increase in [3H]norepinephrine overflow evoked by electrical stimulation but did not prevent that caused by the indirect sympathomimetic tyramine. During blockade of the exocytotic release of norepinephrine with bretylium, the pharmacological displacement of the sympathetic neurotransmitter by tyramine significantly decreased the contractions evoked by electrical stimulation but did not affect contractions caused by exogenous acetylcholine. Metoprolol, a beta 1-adrenergic antagonist, abolished and propranolol significantly reduced the effect of tyramine during electrical stimulation. alpha 2-Adrenergic blockade, beta 2-adrenergic blockade, or removal of the epithelium did not significantly affect the response to tyramine. These results suggest that norepinephrine when released from sympathetic nerve endings can activate prejunctional inhibitory beta 1-adrenoceptors to depress cholinergic neurotransmission in the bronchial wall.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031004     DOI: 10.1152/jappl.1987.62.2.785

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  13 in total

1.  Pre- and post-junctional actions of procaterol, a beta 2-adrenoceptor stimulant, on dog tracheal tissue.

Authors:  Y Ito
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

Review 2.  Airway receptors.

Authors:  P J Barnes
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

3.  Modulation of cholinergic neurotransmission by the peptide VIP, VIP antiserum and VIP antagonists in dog and cat trachea.

Authors:  H Hakoda; Y Ito
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

4.  VIP antagonists enhance excitatory cholinergic neurotransmission in the human airway.

Authors:  H Aizawa; H Inoue; M Shigyo; S Takata; H Koto; K Matsumoto; N Hara
Journal:  Lung       Date:  1994       Impact factor: 2.584

5.  The role of cyclic AMP in non-adrenergic non-cholinergic contraction in guinea-pig bronchi.

Authors:  T Aikawa; K Sekizawa; M Morikawa; S Itabashi; H Sasaki; T Takishima
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

6.  Airway epithelial cells regulate membrane potential, neurotransmission and muscle tone of the dog airway smooth muscle.

Authors:  Z Xie; H Hakoda; Y Ito
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

7.  Airway epithelial cells modulate cholinergic neurotransmission in dog trachea.

Authors:  H Aizawa; K Matsumoto; M Shigyo; H Inoue; H Koto; S Takata; N Hara
Journal:  Lung       Date:  1994       Impact factor: 2.584

8.  Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.

Authors:  A Bergendal; A Lindén; J Lötvall; B E Skoogh; C G Löfdahl
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Modulation of cholinergic neurotransmission in guinea-pig trachea by neuropeptide Y.

Authors:  C D Stretton; P J Barnes
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

10.  Circulating adrenaline and noradrenaline concentrations during exercise in patients with exercise induced asthma and normal subjects.

Authors:  K E Berkin; G Walker; G C Inglis; S G Ball; N C Thomson
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.